AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2016
Nov 16, 2016
33651_dirs_2016-11-15_27e62d22-39c6-4006-b7d3-7905c20f46c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2016-11-01
Reporting Person: Ghiglieri Stephen F (Chief Financial Officer)
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9